The fallacy of average: How using hba1c alone to assess glycemic control can be misleading

Diabetes Care

Volumn 40, Issue 8, 2017, Pages 994-999

  Beck, Roy W ^a   Connor, Crystal G ^a   Mullen, Deborah M ^b   Wesley, David M ^b,c   Bergenstal, Richard M ^b  

^a JAEB CENTER FOR HEALTH RESEARCH   (United States)

^b INTERNATIONAL DIABETES CENTER   (United States)

^c Sursumcorda Resource Group LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ANALYSIS; BLOOD; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE MANAGEMENT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PERSONALIZED MEDICINE; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; FEMALE; GLYCATED HEMOGLOBIN A; HUMANS; MALE; MIDDLE AGED; PRECISION MEDICINE; YOUNG ADULT;

EID: 85028041245     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc17-0636     Document Type: Article

References (28)

1. Rose T. The End of Average: How We Succeed in a World That Values Sameness. New York, Harper Collins, 2015
2. Cohen RM, Franco RS, Khera PK, et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 2008; 112:4284-4291
3. Malka R, Nathan DM, Higgins JM. Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring. Sci Transl Med 2016;8:359ra130
4. Bergenstal RM, Gal RL, Connor CG, et al. Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels. Ann Intern Med. 13 June 2017 [Epub ahead of print]. DOI: 10.7326/M16-2596
5. Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie S, Gould BJ. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia 1990;33:208-215
6. Cohen RM,Haggerty S, HermanWH. HbA1c for the diagnosis of diabetes and prediabetes: is it time for amid-course correction? J Clin Endocrinol Metab 2010;95:5203-5206
7. Cohen RM, Holmes YR, Chenier TC, Joiner CH. Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care 2003;26: 163-167
8. Wilson DM, Kollman; Diabetes Research in Children Network (DirecNet) Study Group. Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors. Diabetes Care 2008;31:381-385
9. Hempe JM, Gomez R, McCarter RJ Jr, Chalew SA. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications 2002;16:313-320
10. Wilson DM, Xing D, Beck RW, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Care 2011;34: 540-544
11. Kilpatrick ES, Rigby AS, Atkin SL. Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control. Clin Chem 2007;53:897-901
12. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA1c: analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial. Diabetes Care 2002;25:275-278
13. Welsh KJ, Kirkman MS, Sacks DB. Role of glycated proteins in the diagnosis and management of diabetes: research gaps and future directions. Diabetes Care 2016;39:1299-1306
14. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473-1478
15. Beck RW, Riddlesworth T, Ruedy K, et al.; DIAMOND Study Group. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA 2017; 317:371-378
16. Beck RW, Riddlesworth TD, Ruedy K, et al. Continuous glucose monitoring vs usual care in type 2 diabetes patients on multiple daily insulin injections: a randomized trial. Ann Int Med. In press
17. Hempe JM, Liu S, Myers L, McCarter RJ, Buse JB, Fonseca V. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care 2015;38:1067-1074
18. Xing D, Kollman C, Beck RW, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring. Diabetes Technol Ther 2011;13:351-358
19. ArgentoNB, Nakamura K, Sala RD, Simpson P. Hemoglobin A1C, mean glucose, and persistence of glycation ratios in insulin-treated diabetes. Endocr Pract 2014;20:252-260
20. Nayak AU, HollandMR,Macdonald DR, Nevill A, Singh BM. Evidence for consistency of the glycation gap in diabetes. Diabetes Care 2011;34: 1712-1716
21. Rodríguez-Segade S, Rodríguez J, García Lopez JM, Casanueva FF, Camiña F. Estimation of the glycation gap in diabetic patients with stable glycemic control. Diabetes Care 2012;35: 2447-2450
22. Wilson DM, Xing D, Cheng J, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Persistence of individual variations in glycated hemoglobin: analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial. Diabetes Care 2011;34: 1315-1317
23. Jaeb Center for Health Research. HbA1c estimator [Internet]. Available from https://www. jaeb.org/a1c/. Accessed 3 June 2017
24. International Diabetes Center, Jaeb Center for Health Research. Links: eA1C calculator. HbA1c estimator [Internet]. Available from www.agpreport. org/agp/links. Accessed 3 June 2017
25. Heller SR, Bergenstal RM, White WB, et al.; EXAMINE Investigators. Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: the EXAMINE trial. Diabetes Obes Metab 2017;19:664-671
26. Lee AK,Warren B, Lee CJ, et al. Association of severe hypogylcemia with cardiovascular disease and all-cause mortality in older adults with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2017;135:A43
27. Bergenstal RM, Ahmann AJ, Bailey T, et al. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther 2013;15:198-211
28. Aleppo G, Ruedy KJ, Riddlesworth TD, et al.; REPLACE-BG Study Group. REPLACE-BG: a randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes. Diabetes Care 2017;40: 538-545